Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J M Trigo

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2018
SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)M Majem, O Juan, A Insa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonationElisabeth Pérez-Ruiz, O Cazorla, M Redondo, et al.
Cancer|January 28, 1999
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trialM Hidalgo, J Hornedo, C Lumbreras, et al.
Neuropharmacology|November 24, 2004
Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatementJ A López-Moreno, J M Trigo-Díaz, F Rodríguez de Fonseca, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 7, 2013
Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancerB Pajares, L Perez-Villa, J M Trigo, et al.
BMC Cancer|December 23, 2019
Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapyI Zapata, M Alvarez, R Hidalgo, et al.
BMC Cancer|October 30, 2016
Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapyJ Gomez-Millan, B Pajares, L Perez-Villa, et al.
Cancer|January 5, 2000
Tumor markers at the time of recurrence in patients with germ cell tumorsJ M Trigo, J M Tabernero, L Paz-Ares, et al.
British Journal of Cancer|October 14, 2005
A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end pointsA O'Donnell, A Padhani, C Hayes, et al.
British Journal of Pharmacology|July 2, 2011
Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatmentsK Elhabazi, J M Trigo, C Mollereau, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 18, 2018
SEOM clinical guidelines for the treatment of non-small cell lung cancer (2018)M Majem, O Juan, A Insa, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|August 3, 2012
Immunohistochemical expression of cyclooxygenase-2 in patients with advanced cancer of the larynx who have undergone induction chemotherapy with the intention of preserving phonationElisabeth Pérez-Ruiz, O Cazorla, M Redondo, et al.
Cancer|January 28, 1999
Outpatient therapy with oral ofloxacin for patients with low risk neutropenia and fever: a prospective, randomized clinical trialM Hidalgo, J Hornedo, C Lumbreras, et al.
Neuropharmacology|November 24, 2004
Nicotine in alcohol deprivation increases alcohol operant self-administration during reinstatementJ A López-Moreno, J M Trigo-Díaz, F Rodríguez de Fonseca, et al.
Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|November 7, 2013
Concurrent radiotherapy plus epidermal growth factor receptor inhibitors in patients with human papillomavirus-related head and neck cancerB Pajares, L Perez-Villa, J M Trigo, et al.
BMC Cancer|December 23, 2019
Causes of death in patients with locally advanced head and neck cancer treated with radiotherapy and systemic therapyI Zapata, M Alvarez, R Hidalgo, et al.
BMC Cancer|October 30, 2016
Subcellular localisation of pMEK has a different prognosis in locally advanced head and neck cancer treated with concomitant radiochemotherapyJ Gomez-Millan, B Pajares, L Perez-Villa, et al.
Cancer|January 5, 2000
Tumor markers at the time of recurrence in patients with germ cell tumorsJ M Trigo, J M Tabernero, L Paz-Ares, et al.
British Journal of Cancer|October 14, 2005
A Phase I study of the angiogenesis inhibitor SU5416 (semaxanib) in solid tumours, incorporating dynamic contrast MR pharmacodynamic end pointsA O'Donnell, A Padhani, C Hayes, et al.
British Journal of Pharmacology|July 2, 2011
Involvement of neuropeptide FF receptors in neuroadaptive responses to acute and chronic opiate treatmentsK Elhabazi, J M Trigo, C Mollereau, et al.
Pageof 3